Helus Pharma's total assets for Q1 2027 were C$259.34M, a decrease of -25.96% from the previous quarter. HELP total liabilities were C$17.55M for the fiscal quarter, a -35.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.